Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form Of &agr;-Synucleinopathy

Hirotake Uchikado, W. L. Lin, M. Delucia, D. Dickson
Published 2006 · Psychology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Lewy bodies (LBs) are &agr;-synuclein-immunoreactive neuronal inclusions with a predilection for specific cortical and subcortical regions, including the amygdala. In this study, the presence of LBs was assessed in 347 cases of Alzheimer disease (AD). In 87 cases, LB pathology was diagnostic of brainstem (n = 3), transitional (n = 32), or diffuse (n = 52) Lewy body disease (LBD). The remaining 260 cases of AD were screened for amygdala LBs (AD/ALB) and 62 (24%) cases were found. If AD/LBD cases are included, LBs were detected in 149 (43%) cases of AD. The presence &agr;-synuclein pathology was assessed in multiple brain regions of the 62 cases of AD/ALB and 57 randomly selected cases of AD, and only sparse &agr;-synuclein pathology was detected in both. The burden of &agr;-synuclein pathology in brainstem nuclei, amygdala, and neocortex was significant lower in AD/ALB than in AD/LBD. In comparison to AD/LBD, AD/ALB did not differ in age at death, disease duration, male-to-female ratio, brain weight, Braak neurofibrillary tangle stage, average senile plaque density, or apolipoprotein E &egr;4 allele frequency. The results suggest that AD/ALB is pathologically different from AD/LBD, suggesting that it is a neuropathologically distinct and isolated &agr;-synucleinopathy.
This paper references
10.1007/s00401-003-0725-y
α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study
K. Jellinger (2003)
10.1126/SCIENCE.1058189
Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP
J. Lewis (2001)
10.1212/01.WNL.0000150892.81839.D1
Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease
D. Tsuang (2005)
10.1093/JNEN/63.7.742
Lewy Body‐Related α‐Synucleinopathy in Aging
Y. Saito (2004)
Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
O. Pletniková (2005)
10.1007/BF00308809
Neuropathological stageing of Alzheimer-related changes
H. Braak (2004)
10.1073/pnas.211412398
β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease
E. Masliah (2001)
10.1016/S0022-510X(01)00689-X
Relationship in the formation process between neurofibrillary tangles and Lewy bodies in the hippocampus of dementia with Lewy bodies brains
E. Iseki (2002)
10.1016/S0006-8993(00)03082-1
α-Synuclein-positive structures in cases with sporadic Alzheimer’s disease: morphology and its relationship to tau aggregation
Yasushi Arai (2001)
The amygdala system
P. Gloor (1997)
The limbic system in Alzheimer's disease. A neuropathologic investigation.
M. W. Hopper (1976)
10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4
Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease
C. F. Lippa (1999)
10.1212/WNL.52.9.1839
Comparison of Lewy body variant of Alzheimer’s disease with pure Alzheimer’s disease
A. Heyman (1999)
Accumulation of phosphorylated alpha-synuclein in aging human brain.
Y. Saito (2003)
10.1097/00002093-200210000-00001
Relative Frequencies of Alzheimer Disease, Lewy Body, Vascular and Frontotemporal Dementia, and Hippocampal Sclerosis in the State of Florida Brain Bank
W. Barker (2002)
10.1007/s00401-004-0869-4
Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer’s disease
W. Marui (2004)
10.1016/S0002-9440(10)63812-6
Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation.
W. Lin (2003)
10.1016/0022-510X(90)90236-G
Senile dementia of Lewy body type: A clinically and neuropathologically distinct form of Lewy body dementia in the elderly
R. Perry (1990)
10.1016/j.expneurol.2004.12.002
α-Synuclein: A potent inducer of tau pathology
J. Geddes (2005)
10.1007/s004010050454
Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer’s disease and Lewy body disorders
M. L. Schmidt (1996)
alpha-Synuclein: a potent inducer of tau pathology.
J. Geddes (2005)
10.1097/01.jnen.0000218449.17073.43
Lewy Bodies in Progressive Supranuclear Palsy Represent an Independent Disease Process
Hirotake Uchikado (2006)
10.1007/BF00314594
Diffuse lewy body disease in Japan
K. Kosaka (2004)
10.1097/00019052-200108000-00001
Alpha-synuclein and the Lewy body disorders.
D. Dickson (2001)
10.1016/0197-4580(92)90027-U
Identification of normal and pathological aging in prospectively studied nondemented elderly humans
D. Dickson (1992)
10.1016/0165-0270(94)90168-6
Single-day apolipoprotein E genotyping
R. Crook (1994)
10.1016/S0987-7053(00)88869-3
The temporal lobe and the limbic system
J. M. Guérit (2000)
10.1097/00004691-199805000-00038
The Temporal Lobe and Limbic System
J. Engel (1998)
10.1136/jnnp.51.6.745
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
W. Gibb (1988)
Unauthorized reproduction of this article is prohibited Association of an extended haplotype in the tau gene with progressive supranuclear palsy
M Litvan (1999)
10.1212/WNL.62.1.160
Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies
K. Jellinger (2004)
10.1016/0022-510X(90)90029-M
Neuropathological study of the amygdala in presenile Alzheimer's disease
K. Tsuchiya (1990)
10.1097/00019442-200305000-00016
Cognitive burden and excess Lewy-body pathology in the Lewy-body variant of Alzheimer disease.
M. Serby (2003)
10.1111/j.1365-2990.1986.tb00053.x
THE TOPOGRAPHY OF PLAQUES AND TANGLES IN DOWN'S SYNDROME PATIENTS OF DIFFERENT AGES
D. Mann (1986)
Neurophysiology and functions of the primate amygdala.
E. Rolls (1992)
10.1016/S0022-510X(99)00327-5
Occurrence of human α-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer’s disease
W. Marui (2000)
10.1007/s00401-005-0022-z
Coexistence of PSP and MSA: a case report and review of the literature
Hirotake Uchikado (2005)
Alpha-synuclein pathology in Parkinson_s and Alzheimer_s disease brain: incidence and topographic distributionVa pilot study
KA Jellinger (2003)
10.1093/CERCOR/1.1.103
The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease.
S. E. Arnold (1991)
10.1016/S0002-9440(10)65722-7
Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.
C. F. Lippa (1998)
Diagnosis of Alzheimer's disease.
C. Filley (1988)
10.1093/JNEN/62.4.363
Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease.
L. Parkkinen (2003)
10.1093/BRAIN/AWF033
Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.
A. Harding (2002)
10.1016/S0165-0173(02)00248-5
The human amygdala and the emotional evaluation of sensory stimuli
D. Zald (2003)
10.1016/0304-3940(96)12775-0
Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease
P. Rezaie (1996)
10.1212/WNL.42.3.631
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
P. Arriagada (1992)
10.1007/s004010051177
Distinctive neuropathology revealed by α-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p
K. Gwinn-Hardy (2000)
10.1126/SCIENCE.1082324
Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein
B. Giasson (2003)
10.1093/JNEN/64.2.156
Alpha-Synuclein Lesions in Normal Aging, Parkinson Disease, and Alzheimer Disease: Evidence from the Baltimore Longitudinal Study of Aging (BLSA)
Irina Mikolaenko (2005)
Lewy body-related alpha-synucleinopathy in aging.
Y. Saito (2004)
10.1093/JNEN/62.6.644
Accumulation of Phosphorylated α‐Synuclein in Aging Human Brain
Y. Saito (2003)
10.1016/S0197-4580(02)00065-9
Staging of brain pathology related to sporadic Parkinson’s disease
H. Braak (2003)
10.1111/j.1750-3639.2000.tb00269.x
Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein Immunohistochemistry
R. Hamilton (2000)
10.1097/00005072-199710000-00002
Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease
B. Hyman (1997)
10.1212/WNL.40.1.1
The Lewy body variant of Alzheimer's disease
L. Hansen (1990)
beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.
E. Masliah (2001)
Occurrence of human alpha-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer's disease.
W. Marui (2000)
10.1212/01.wnl.0000187889.17253.b1
Diagnosis and management of dementia with Lewy bodies
I. McKeith (2005)
10.3233/JAD-2006-9S347
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.
I. McKeith (1996)
10.1212/WNL.54.9.1774
Predictors of progression in patients with AD and Lewy bodies
O. Lopez (2000)
10.1093/HMG/8.4.711
Association of an extended haplotype in the tau gene with progressive supranuclear palsy.
M. Baker (1999)
10.1016/S0304-3940(99)00178-0
Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease
E. Iseki (1999)
10.1016/j.neurobiolaging.2004.10.006
Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases
O. Pletniková (2005)
10.1016/0197-4580(94)90143-0
Neuron loss and shrinkage in the amygdala in Alzheimer's disease
T. H. Vereecken (1994)
10.1016/S0022-510X(02)00006-0
Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies
W. Marui (2002)



This paper is referenced by
Studying the Interactions Between Tau, Amyloid, and α-Synuclein in Alzheimer’s Disease Animal and Human Cell Models
Wesley Chen (2016)
10.1001/jamaneurol.2015.0606
Clinical Features of Alzheimer Disease With and Without Lewy Bodies.
E. J. Chung (2015)
10.1371/journal.pone.0231720
Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer’s disease dementia
T. Beach (2020)
10.1080/13554794.2017.1420199
Multiproteinopathy, neurodegeneration and old age: a case study
J. C. Rojas (2018)
10.1111/j.1469-7580.2007.00748.x
Alpha‐synuclein pathology in the olfactory pathways of dementia patients
P. Hubbard (2007)
10.1097/NEN.0b013e3181ac10a7
Lewy Body Pathology in Normal Elderly Subjects
W. Markesbery (2009)
Alpha-synuclein expression influences the processing of the amyloid precursor protein
H. Roberts (2016)
10.1111/j.1742-4658.2012.08489.x
Role of α‐synuclein penetration into the membrane in the mechanisms of oligomer pore formation
I. Tsigelny (2012)
10.1016/j.pneurobio.2012.03.005
Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia
I. Ferrer (2012)
10.1016/j.parkreldis.2012.10.013
Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease.
T. Ferman (2013)
10.1111/j.1750-3639.2008.00169.x
Clinicopathological Outline of Dementia with Lewy Bodies Applying the Revised Criteria: The Hisayama Study
Kouhei Fujimi (2008)
10.1111/j.1365-2990.2007.00874.x
Parkinson's disease: a dual‐hit hypothesis
C. Hawkes (2007)
10.1016/j.neurobiolaging.2009.05.019
Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies?
R. Frigerio (2011)
10.3390/ijms17020189
Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine
G. Kovacs (2016)
10.1111/bpa.12843
Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases
Miki Tomoko (2020)
10.1007/s00415-009-5243-y
Formation and development of Lewy pathology: a critical update
K. Jellinger (2009)
10.1136/jclinpath-2019-205952
Molecular pathology of neurodegenerative diseases: principles and practice
G. Kovacs (2019)
10.1007/s00401-017-1709-7
Interactions of pathological proteins in neurodegenerative diseases
T. Spires-Jones (2017)
10.1021/acsomega.0c01819
Testing Amyloid Cross-Toxicity in the Vertebrate Brain
G. Henríquez (2020)
10.1016/j.nbd.2019.104708
Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions
Lindsay Stoyka (2020)
10.1007/s00401-007-0193-x
Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons
H. Braak (2007)
10.1002/mds.22065
Progranulin gene mutation with an unusual clinical and neuropathologic presentation
C. Wider (2008)
10.1002/9781444341256.CH22
Dementia with Lewy Bodies and Parkinson's Disease Dementia
P. Ince (2011)
10.3233/JPD-179001
Neuropathological Staging of Brain Pathology in Sporadic Parkinson’s disease: Separating the Wheat from the Chaff
H. Braak (2017)
10.4102/SAFP.V61I2.4999
Understanding Alzheimer disease
M. Vally (2019)
10.1097/NEN.0b013e3181c6b84d
Clinical, Neuropathologic, and Biochemical Profile of the Amyloid Precursor Protein I716F Mutation
C. Guardia-Laguarta (2010)
10.1212/WNL.0000000000001171
The amygdala
E. Benarroch (2015)
10.1016/j.trci.2016.09.002
Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development
G. Rabinovici (2017)
10.1007/s00401-011-0819-x
A peculiar constellation of tau pathology defines a subset of dementia in the elderly
G. Kovacs (2011)
10.1007/s00401-008-0347-5
Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
K. Jellinger (2008)
10.1111/psyg.12054
Corticobasal degeneration initially developing motor versus non‐motor symptoms: a comparative clinicopathological study
C. Ikeda (2014)
Newsletter der Österreichischen Parkinson Gesellschaft
R. Katzenschlager (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar